Posts

Ohio State Discoveries Highlight Colon Cancer Preventio...

Researchers at The Ohio State University Comprehensive Cancer Center – Arthur G....

New Study Reveals Increased Risk of Severe RSV Outcomes...

A groundbreaking study presented at the upcoming Pediatric Academic Societies (P...

MEF2A, C, D: New Pancreatic Cancer Biomarkers

In a groundbreaking new study, researchers have shed light on the crucial role o...

Scientists Develop ‘Super Stem Cells’ Paving the Way fo...

Imagine a world where simply altering the metabolic environment of stem cells co...

Probiotics Boost Recovery After Radical Gastrectomy

In a groundbreaking initiative poised to influence the future of gastric cancer ...

Suppressor Protein and Inflammation in Colorectal Cancer

Colorectal cancer (CRC) ranks among the most prevalent and lethal malignancies w...

Chinese CRO GemPharmatech Expands in San Diego as FDA R...

The Chinese contract research organization (CRO) GemPharmatech continues to incr...

Click Therapeutics Gains FDA Clearance for First Prescr...

Click Therapeutics has secured a notable regulatory milestone with the U.S. Food...

VelaVigo Bio Strikes Second Major Licensing Agreement, ...

In a continued series of strategic moves, VelaVigo Bio, a biotechnology firm bas...

Biolinq Secures $100 Million to Advance Glucose Biosens...

Biolinq has announced the successful closure of a $100 million venture capital i...

Roche offers $50 billion to US pharma production in res...

Roche, the drugmaker giant, announced its interest in investing $50 billion over...

Veraxa to go public in $1.6bn SPAC deal with Voyager

Veraxa Biotech will gain access to $253m in cash from Voyager to advance its can...

Synthetic hormones and the future of contraception

Contraception for women has seen little change over the past 50 years, with the ...

EditCo Bio secures access to Promega’s technologies in ...

EditCo Bio has entered a licensing agreement to secure access to Promega’s prote...

FDA layoffs and priority review programme’s lapse disru...

The expiration of the FDA’s paediatric priority review voucher programme is crea...

Boehringer to expand oncology presence with $572m Tesse...

The agreement gives Boehringer access to Tessellate’s novel approach targeting A...